Carfilzomib, daratumumab, and dexamethasone (KdD) vs. lenalidomide-sparing pomalidomide-containing triplet regimens for relapsed/refractory multiple myeloma: an indirect treatment comparison.

Saved in:
Bibliographic Details
Title: Carfilzomib, daratumumab, and dexamethasone (KdD) vs. lenalidomide-sparing pomalidomide-containing triplet regimens for relapsed/refractory multiple myeloma: an indirect treatment comparison.
Authors: Weisel, Katja1 (AUTHOR), Dimopoulos, Meletios A.2 (AUTHOR), Beksac, Meral3 (AUTHOR), Leleu, Xavier4 (AUTHOR), Richter, Joshua5 (AUTHOR), Heeg, Bart6 (AUTHOR), Patel, Sachin7 (AUTHOR), Majer, Istvan8 (AUTHOR), McFadden, Ian9 (AUTHOR), Mikhael, Joseph10 (AUTHOR) jmikhael@myeloma.org
Source: Leukemia & Lymphoma. Apr2024, Vol. 65 Issue 4, p481-492. 12p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 175639281
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Carfilzomib, daratumumab, and dexamethasone (KdD) vs. lenalidomide-sparing pomalidomide-containing triplet regimens for relapsed/refractory multiple myeloma: an indirect treatment comparison.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Weisel%2C+Katja%22">Weisel, Katja</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Dimopoulos%2C+Meletios+A%2E%22">Dimopoulos, Meletios A.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Beksac%2C+Meral%22">Beksac, Meral</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Leleu%2C+Xavier%22">Leleu, Xavier</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Richter%2C+Joshua%22">Richter, Joshua</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Heeg%2C+Bart%22">Heeg, Bart</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Patel%2C+Sachin%22">Patel, Sachin</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Majer%2C+Istvan%22">Majer, Istvan</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22McFadden%2C+Ian%22">McFadden, Ian</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Mikhael%2C+Joseph%22">Mikhael, Joseph</searchLink><relatesTo>10</relatesTo> (AUTHOR)<i> jmikhael@myeloma.org</i>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Leukemia+%26+Lymphoma%22">Leukemia & Lymphoma</searchLink>. Apr2024, Vol. 65 Issue 4, p481-492. 12p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=175639281
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1080/10428194.2023.2300051
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 12
        StartPage: 481
    Titles:
      – TitleFull: Carfilzomib, daratumumab, and dexamethasone (KdD) vs. lenalidomide-sparing pomalidomide-containing triplet regimens for relapsed/refractory multiple myeloma: an indirect treatment comparison.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Weisel, Katja
      – PersonEntity:
          Name:
            NameFull: Dimopoulos, Meletios A.
      – PersonEntity:
          Name:
            NameFull: Beksac, Meral
      – PersonEntity:
          Name:
            NameFull: Leleu, Xavier
      – PersonEntity:
          Name:
            NameFull: Richter, Joshua
      – PersonEntity:
          Name:
            NameFull: Heeg, Bart
      – PersonEntity:
          Name:
            NameFull: Patel, Sachin
      – PersonEntity:
          Name:
            NameFull: Majer, Istvan
      – PersonEntity:
          Name:
            NameFull: McFadden, Ian
      – PersonEntity:
          Name:
            NameFull: Mikhael, Joseph
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 04
              Text: Apr2024
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-print
              Value: 10428194
          Numbering:
            – Type: volume
              Value: 65
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: Leukemia & Lymphoma
              Type: main
ResultId 1